Evidence map›Paper›PMID 21869457›Full record

ReviewAging2011

Polyamines in aging and disease.

Nadège Minois, Didac Carmona-Gutierrez, Frank Madeo

3 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 271 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02755246 phase2completednot on this mapstarted 2016, after this paper: background citation

Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function in Healthy Older Adults With Subjective Cognitive Decline

TypeinterventionalSponsorCharite University, Berlin, GermanyRan2016 to 2016Enrolled30ConditionsSubjective Cognitive DeclineArmsPolyamine supplementation, Placebo supplementation
NCT03094546 phase2completednot on this mapstarted 2017, after this paper: background citation

Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function and Biomarkers in Elderly Individuals With Subjective Cognitive Decline

TypeinterventionalSponsorCharite University, Berlin, GermanyRan2017 to 2020Enrolled100ConditionsSubjective Cognitive Decline (SCD)ArmsPolyamine, Placebo
NCT07383311 narecruitingnot on this mapstarted 2025, after this paper: background citation

Autophagy-Enhancers to Reduce Sleep Disturbances: A Combined Approach

TypeinterventionalSponsorUniversity Medicine GreifswaldRan2025 to 2029Enrolled76ConditionsMild Cognitive Impairment Due to Alzheimer's Disease, Subjective Cognitive Decline (SCD)ArmsSpermidine Supplementation, Dietary Placebo
3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 3 syntheses or guidelines pooled it, 500 citations in OpenAlex.

  1. Pooled it
  2. Metabolomics in Glaucoma: A Systematic Review.Investigative ophthalmology & visual science · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Polyamines are i-motif disruptors.Molecular therapy. Nucleic acids · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  20. Review

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Nadège MinoisUniversity of St Andrews, School of Biology, St Andrews, Fife, UK. nm61@st-andrews.ac.uk
Didac Carmona-Gutierrez
Frank Madeo
University of Graz · ATUniversity of St Andrews · GB

Funding

Austrian Science Fund FWF P 23490
6 · The paper itself

Abstract

Polyamines are polycations that interact with negatively charged molecules such as DNA, RNA and proteins. They play multiple roles in cell growth, survival and proliferation. Changes in polyamine levels have been associated with aging and diseases. Their levels decline continuously with age and polyamine (spermidine or high-polyamine diet) supplementation increases life span in model organisms. Polyamines have also been involved in stress resistance. On the other hand, polyamines are increased in cancer cells and are a target for potential chemotherapeutic agents. In this review, we bring together these various results and draw a picture of the state of our knowledge on the roles of polyamines in aging, stress and diseases.

Indexed as

AgingAnimalsBiological TransportHumansNeoplasmsPolyaminesStress, PhysiologicalPolyamines

Identifiers

PMID21869457
PMCPMC3184975
OpenAlexW2104047392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.